An interdisciplinary integrative approach to pregnancy management in benign and borderline ovarian tumors: a case report and а literature review
https://doi.org/10.18027/2224-5057-2020-10-3-34-39
Abstract
The management and treatment of patients with various malignancies during pregnancy appears to be a pressing issue to date. Ovarian tumors take the 4th place among all neoplasms diagnosed during pregnancy. The study aimed to investigate an interdisciplinary integrative approach to pregnancy management in case of benign and borderline ovarian tumors.
The article presents the analysis of the pregnancy course in women with borderline and malignant ovarian tumors. When detecting a tumor during pregnancy, obstetric and surgical tactics is determined in a multidisciplinary team together with an oncologist.
It is possible not only to prolong pregnancy without additional chemotherapy but also to preserve fertility in the future in patients with borderline tumors and stage I malignant tumors.
About the Authors
E. V. KozyrkoRussian Federation
Elena V. Kozyrko, Researcher, Researcher, Obstetrics Department
Moscow
G. R. Alieva
Russian Federation
Gulnara R. kyzy Alieva, 2nd year Resident
Moscow
A. I. Akhmedova
Russian Federation
Aminat I. Akhmedova, MD, PhD, oncologist, Obstetric Physiological Department
Moscow
S. V. Khokhlova
Russian Federation
Svetlana V. Khokhlova, Head of the Oncology Department, Anticancer Drug Therapy
Moscow
R. G. Shmakov
Russian Federation
Roman G. Shmakov, Director, Institute of Obstetrics
Moscow
References
1. Andrijono. Kanker Ovarium. Dalam: Sinopsis Kanker Ginekologi. Edisi Keempat. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia, 2013.
2. WHO: International Agency for Research on Cancer. Globocan 2012: Estimated Cancer Incidence, Mortality, Prevalence Worldwide in 2012. [Cited 2017 December 10]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.2012
3. The world ovarian cancer coalition atlas. Global trends in incidence, mortality and surviva. World Ovarian Cancer Coalition 2020. Author Frances Reid Programme Director, World Ovarian Cancer Coalition Reviewers Dr Manas Chakrabarti Diane Gardiner Robyn Maxwell. P. 4–7
4. This report has been produced and funded by the World Ovarian Cancer Coalition © World Ovarian Cancer Coalition 2018 Study Director: Frances Reid Expert Advisory Panel Co ‑ Chairs: Professor Neerja Bhatla and Annwen Jones l April 2018. P. 7–10
5. Оncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20‑year international cohort study of 1170 patients de Haan J., Verheecke M., Han S. N., Amant F., Van Calsteren K., Van Calster B., de Groot C. J. M., Shmakov R. G., Polushkina E., Sukhikh G. T., Mhallem Gziri M., Halaska M. J., Rob L., Fruscio R., Ceppi L., Lok C. A. R., Boere I. A., Zola P., Ottevanger P. B., Peccatori F. A. et al. The Lancet Oncology. 2018. Т. 19. № 3. С. 337–346.
6. Goff B. A., Mandel L. S., Melancon C. H., Muntz H. G. Fre‑ quency of symptoms of ovarian cancer in women presenting to primary care clinics / / JAMA.— 2004.— Vol. 291.— P. 2705.
7. Goff B. A., Mandel L. S., Drescher C. W. et al. Develop ‑ment of an ovarian cancer symptom index: possibilities for earlier detection / / Cancer.— 2007.— Vol. 109.— P. 221
8. Серов В. Н. Шмаков Р. Г. Полушкина Е. С., Волочаева М. В. Рак и беременность / / РМЖ. Мать и дитя. 2015. № 20. С. 1195–1197.
9. de Haan J, Vandecaveye V, Han SN, Van de Vijver KK, Amant F. Difficulties with diagnosis of malignancies in pregnancy / / Best Pract Res Clin Obstet Gynaecol. 2016. Vol. 33. P. 19–32.
10. Martínez MT, Bermejo B, Hernando C, Gambardella V, Cejalvo JM, Lluch A. Breast cancer in pregnant patients: A review of the literature / / Eur J Obstet Gynecol Reprod Biol. 2018. Vol. 230. P. 222–22
11. Maggen C, van Gerwen M, Van Calsteren K, Vandenbroucke T, Amant F. Management of cancer during pregnancy and current evidence of obstetric, neonatal and pediatric outcome: a review article / / Int J Gynecol Cancer. 2019. Vol. 29. P. 404–416.
12. Peccatori FA, Azim HA Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, Pentheroudakis G; ESMO Guidelines Working Group. Сancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‑up / / Ann Oncol. 2013. Vol. 24. № 6. P. Р. vi160–170
13. Hsieh TC1, Wu YC, Sun SS, Chu LY, Yen KY, Kao CH. FDG PET / CT of a late‑term pregnant woman with breast cancer / / Clin Nucl Med. 2012. Vol. 37. № 5. P. 489–491.
14. Takalkar AM, Khandelwal A, Lokitz S, Lilien DL, Stabin MG. 18F-FDG PET in Pregnancy and Fetal Radiation Dose Estimates / / J Nucl Med. 2011. Vol. 52. № 7. P. 1035–1040
15. Кузнецов В. В. Диагностика метастатического поражения скелета / / Тюменский мед журнал. 2013. Т. 15. № 4. С. 31–3
16. Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes / / JAMA. 2016. Vol. 316. № 9. Р. 952–961
17. Леваков С. А., Боровкова Е. И. Особенности течения рака молочной железы в сочетании с беременностью (обзор литературы) / / Акушерство и гинекология: новости, мнения, обучение. 2014. № 2 (4). С. 88, 91–96.
18. Zubor P, Kubatka P, Kapustova I, Miloseva L, Dankova Z, Gondova A, Bielik T, Krivus S, Bujnak J, Laucekova Z, Kehrer C, Kudela E, Danko J. Current approaches in the clinical management of pregnancy‑associated breast cancer‑pros and cons // EPMA J. 2018. Vol. 9. № 3. P. 257‑270
Review
For citations:
Kozyrko E.V., Alieva G.R., Akhmedova A.I., Khokhlova S.V., Shmakov R.G. An interdisciplinary integrative approach to pregnancy management in benign and borderline ovarian tumors: a case report and а literature review. Malignant tumours. 2020;10(3):34-39. (In Russ.) https://doi.org/10.18027/2224-5057-2020-10-3-34-39